Aperion Biologics announced it has received CE Mark approval for its Z-Lig ACLR device.
The Z-Lig is the first engineered biologic device for treatment of revision and multiligament anterior cruciate ligament knee reconstruction to be granted a CE Mark.
Aperion Biologics is a privately owned, medical device company focused on addressing the need for alternatives to human-based grafts with animal-based tissue technology.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws